Changhe Yu

Changhe Yu

Auto-generated profile, based on publicly available information

Changhe Yu

Tuina and Pain Management Department, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
LQLunxue Qing
Lunxue Qing
YZYingying Zhu
Yingying Zhu
LFLan Feng
Lan Feng
XWXiyou Wang
Xiyou Wang
YSYa-Nan Sun
Ya-Nan Sun
NJNi Jinxia
Ni Jinxia
Objectives This study explored the association between the Frailty Index (FI) and low back pain (LBP) in middle-aged and older Chinese adults. We hypothesised that a higher FI correlates with increased LBP prevalence. Design Cross-sectional analysis. Setting The study used data from the China Health and Retirement Longitudinal Study (CHARLS) across various regions of China. Participants The analysis included 6375 participants aged 45 and above with complete LBP and FI data from the CHARLS for 2011, 2013 and 2015. We excluded individuals under 45, those with incomplete LBP data, participants with fewer than 30 health deficit items and those missing covariate data. Outcome measures We constructed an FI consisting of 35 health deficits. Logistic multivariable regression examined the relationship between FI and LBP, using threshold analysis to identify inflection points. Sensitivity analyses were performed to ensure the robustness of the findings. Results Of the participants, 27.2% reported LBP. A U-shaped association was observed between FI and LBP, with the highest quartile (Q4, FI ≥0.23) showing more than a twofold increased risk of LBP (OR=2.90, 95% CI: 2.45–3.42, p<0.001). Stratified analysis showed a significant association in participants under 60, particularly in the lowest FI quartile (OR=1.43, 95% CI: 1.14 to 1.79). Sensitivity analysis upheld the robustness of the primary results. Conclusions The findings suggest a complex relationship between frailty and LBP, highlighting the need for early screening and tailored interventions to manage LBP in this demographic. Further research is necessary to understand the mechanisms of this association and to validate the findings through longitudinal studies.

1 May 2024 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
XLXia Li
Xia Li
YSYanan Sun
Yanan Sun
YWYuhan Wang
Yuhan Wang
XWXiyou Wang
Xiyou Wang
CYChanghe Yu
Changhe Yu
Objective: This research aimed to assess the effectiveness of manual therapy in alleviating pain among women undergoing primary dysmenorrhea (PD). Methods: All randomized controlled trials (RCTs) regarding manual therapy for PD were searched from online databases, spanning from their inception to July 2023. The identified literature underwent a thorough screening process, and the data were meticulously extracted and analyzed using RevMan 5.3. Subsequently, the included studies underwent Cochrane’s quality assessment and meta-analysis. The evidence obtained was then assessed using the grading of recommendations, assessment, development, and evaluation (GRADE) approach. Results: 32 RCTs, involving 2566 women were finally included for analysis. The overall quality of the concluding evidence was generally rated as low or very low. Performance bias and blind bias were found to be the main risk of bias of the included studies. In comparison to no treatment, manual therapy demonstrated a significant increase in pain relief in short-term (n=191, MD=1.30, 95% CI: 0.24~2.37). The differences in the effects of manual therapy and the placebo on pain intensity may not be statistically significant (n=255, MD=0.10, 95% CI: − 0.37~0.58). In contrast to NSAIDs, manual therapy exhibited superior pain alleviation (n=507, MD=3.01, 95% CI: 1.08~4.94) and a higher effective rate (n=1029, OR=4.87, 95% CI: 3.29~7.20). Importantly, no severe adverse events were reported across all studies, indicating a relatively safe profile for manual therapy. Conclusion: Manual therapy presented promise in effectively relieving menstrual pain with minimal adverse events in short term, outperforming both no treatment and NSAIDs. However, this conclusion is tempered by the low quality of the included RCTs, highlighting the necessity for more robust trials to validate it.

1 January 2008 in Journal of Nippon Medical School
Verified
Journal Article
Open access
PDF file
CWChunyan Wang
Chunyan Wang
SAShinji Abe
Shinji Abe
KMKuniko Matsuda
Kuniko Matsuda
CYChanghe Yu
Changhe Yu
YLYingji Li
Yingji Li
SKShoji Kudoh
Shoji Kudoh
Clinical studies have demonstrated that gefitinib, an epidermal growth factor receptor inhibitor, is an effective treatment for some patients with advanced non-small cell lung cancer and is generally well-tolerated. However, several reports have also suggested that gefitinib is associated with acute lung injury and subsequent fibrosis. One hypothesis is that gefitinib exacerbates lung injury induced by radiation therapy. It is important to confirm the safety of gefitinib in radiotherapy for patients with lung cancer. In this preclinical study we aimed to clarify the effect of gefitinib on thoracic radiotherapy. Six-week-old female C57BL/6 mice were immobilized in a plastic frame, and the thorax was irradiated once with a dose of 12 Gy on day 0. Gefitinib (20, 90 and 200 mg/kg/day) was administered on days 0 to 5 (acute phase) or days 14 to 19 (late phase) postirradiation. Thoracic irradiation induced lung injury and subsequent fibrosis 5 months later. Gefitinib, administered in the acute phase, had no effect on lung fibrosis or collagen levels induced by irradiation. A high dose of gefitinib (200 mg/kg/day) administered during the late phase significantly reduced fibrosis scores and collagen levels. These results suggest that gefitinib does not exacerbate radiation-induced lung injury and fibrosis in this strain of mice. Therefore, thoracic irradiation is unlikely to be a risk factor for lung injury associated with gefitinib treatment.

16 October 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
YSYa-Nan Sun
Ya-Nan Sun
YAYi An
Yi An
ZWZhi-Wen Weng
Zhi-Wen Weng
YZYan-Ji Zhou
Yan-Ji Zhou
XWXi-You Wang
Xi-You Wang
CYChang-He Yu
Chang-He Yu
Objectives Most Asian countries have employed Chinese medicine (CM) and Western medicine to treat lumbar spinal stenosis (LSS). Evidence synthesis and comparison of effectiveness are difficult since outcomes examined and presented through trials possess heterogeneity. This study aimed to solve the outcome problems for CM clinical trials in LSS by building a core outcome set (COS). Methods To achieve an agreement on a set of core outcome domains, a four-phase study was carried out. First, we identified candidate outcome domains by systematically reviewing trials. In addition, we identified outcome domains associated with patients by conducting semistructured interviews with patients. Next, outcome domains were processed through a national two-round Delphi survey, in which 18 patients and 21 experts were recruited. Finally, the above domains were converted as a core outcome domain set based on a consensus meeting, in which 24 stakeholders were recruited. Results Seventeen outcome subdomains were identified by the systematic review and interviews. The Delphi survey assigned a priority to four outcome domains in the first round and four outcomes additionally in the second round. The core outcome domains were determined through discussion and redefinition of outcomes in the consensus meeting: pain and discomfort, health-related quality of life, lumbar function, activities of daily living, measures of walking, patient global assessment, adverse events and CM-specific outcomes. Conclusion COS-CM-LSS is likely to enhance the consistency of outcomes reported in clinical trials. In-depth research should be conducted for the exploration of the best methods to examine the above outcomes.

13 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YGYi-Xuan Gao
Yi-Xuan Gao
ZWZhi-Wen Weng
Zhi-Wen Weng
HSHui Shao
Hui Shao
HBHan Bo
Han Bo
ZCZhi-Hui Chen
Zhi-Hui Chen
CYChang-He Yu
Chang-He Yu
The Zurich Claudication Questionnaire (ZCQ) has been translated and validated in multiple languages but few people have verified the measurement performance of the Chinese version of Zurich Claudication Questionnaire (Ch-ZCQ). The purpose of this study is to assess the performance of the Ch-ZCQ in lumbar spinal stenosis (LSS) patients undergoing non-surgical treatment. It includes the reliability, validity, responsiveness and minimally clinical important difference (MCID) of the two dimensions of symptom severity (SS) and physical function (PF). The results shows that the internal consistency and test-retest reliability were good. The content validity index was 0.764. The structural validity was good and moderate suitability. The correlation between the two dimensions of ZCQ is good, which is strongly correlated with Oswestry Disability Index (ODI) and moderately correlated with 12-item Short Form Health Survey Version 2(SF-12v2). Discriminative validity had significant differences in the degree of classification. The ZCQ’s SS and PF dimensions demonstrated a moderate Effect Size (ES) of 0.46 and 0.35. The Standardized Response Mean (SRM) was low, with values of 0.34 and 0.25. Additionally, the Change Rate (CR) was 10% for both, indicating a low level of change. MCID SS= -0.21[95% CI (-0.36, -0.05)]; MCID PF= -0.16[95% CI (-0.36, -0.03)]. This study demonstrates the Ch-ZCQ to be a reliable and valid tool, which can effectively evaluate the effectiveness of nonsurgical treatments for patients with LSS. However, to optimize its application for the Chinese population, further refinement is needed to address the ceiling/floor effects of some items.

24 July 2025 in Scientific Reports
Verified
Journal Article
Open access
YGYi-Xuan Gao
Yi-Xuan Gao
ZWZhi-Wen Weng
Zhi-Wen Weng
HSHui Shao
Hui Shao
HBHan Bo
Han Bo
ZCZhi-Hui Chen
Zhi-Hui Chen
CYChang-He Yu
Chang-He Yu